- Home
- KOD vs IMOS Comparison
KOD vs IMOS Comparison
Compare KOD & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- IMOS
- Stock Information
- Founded
- KOD 2009
- IMOS 1997
- Country
- KOD United States
- IMOS Taiwan
- Employees
- KOD N/A
- IMOS N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- IMOS Semiconductors
- Sector
- KOD Health Care
- IMOS Technology
- Exchange
- KOD Nasdaq
- IMOS Nasdaq
- Market Cap
- KOD 795.5M
- IMOS 713.8M
- IPO Year
- KOD 2018
- IMOS N/A
- Fundamental
- Price
- KOD $14.14
- IMOS $20.15
- Analyst Decision
- KOD Buy
- IMOS
- Analyst Count
- KOD 6
- IMOS 0
- Target Price
- KOD $14.33
- IMOS N/A
- AVG Volume (30 Days)
- KOD 1.2M
- IMOS 13.0K
- Earning Date
- KOD 11-13-2025
- IMOS 11-04-2025
- Dividend Yield
- KOD N/A
- IMOS 3.21%
- EPS Growth
- KOD N/A
- IMOS N/A
- EPS
- KOD N/A
- IMOS 0.01
- Revenue
- KOD N/A
- IMOS $777,452,000.00
- Revenue This Year
- KOD N/A
- IMOS $3.76
- Revenue Next Year
- KOD N/A
- IMOS $5.93
- P/E Ratio
- KOD N/A
- IMOS $120.57
- Revenue Growth
- KOD N/A
- IMOS 0.89
- 52 Week Low
- KOD $1.92
- IMOS $12.78
- 52 Week High
- KOD $19.39
- IMOS $22.79
- Technical
- Relative Strength Index (RSI)
- KOD 54.23
- IMOS 59.44
- Support Level
- KOD $10.94
- IMOS $19.24
- Resistance Level
- KOD $15.52
- IMOS $20.91
- Average True Range (ATR)
- KOD 1.55
- IMOS 0.42
- MACD
- KOD -0.22
- IMOS -0.11
- Stochastic Oscillator
- KOD 49.68
- IMOS 57.78
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.